Your feedback provides us with vital information that assists in the development of future educational initiatives.
Assessment of Learning Objectives

Using a scale of poor to excellent, please indicate your level of confidence in the learning objective as it relates to your knowledge, belief, or behavior, pre-program and post-program.

Question Title

* Diabetes and Heart Failure: What must a diabetologist know?  | Shelley Zieroth, MD

Your knowledge of screening, diagnosis and management of heart failure in patients with diabetes:

  Poor Fair Good Very Good Excellent
Before
After

Question Title

* Your knowledge of the new therapeutics (including SGLT2i) in the prevention and treatment of heart failure in patients with diabetes:

  Poor Fair Good Very Good Excellent
Before
After

Question Title

* Effectiveness of Speaker:

Question Title

* Additional comments:

Question Title

* Obesity and Diabetes | Sean Wharton, MD

Your knowledge of non-pharmacologic and pharmacologic management of obesity in patients with diabetes:

  Poor Fair Good Very Good Excellent
Before
After

Question Title

* Your knowledge of recommendations pertaining to bariatric surgery in patients with diabetes and obesity:

  Poor Fair Good Very Good Excellent
Before
After

Question Title

* Effectiveness of Speaker:

Question Title

* Additional comments:

Question Title

* Decolonizing Diabetes Health Care | Randal Bell

Your knowledge of the prevalence of diabetes in Indigenous communities:

  Poor Fair Good Very Good Excellent
Before
After

Question Title

* Your knowledge of the current systemic barriers to Indigenous health and diabetes management:

  Poor Fair Good Very Good Excellent
Before
After

Question Title

* Your knowledge of strategies and initiatives to reduce the burden of diabetes in Indigenous people:

  Poor Fair Good Very Good Excellent
Before
After

Question Title

* Effectiveness of Speaker:

Question Title

* Additional comments:

Question Title

* Update on Incretin Therapies | Alice Cheng, MD

Your knowledge of the evolution of the role of incretin therapies in the contemporary management of diabetes:

  Poor Fair Good Very Good Excellent
Before
After

Question Title

* Your knowledge of the therapeutic potential and future applications of triple agonist therapy:

  Poor Fair Good Very Good Excellent
Before
After

Question Title

* Effectiveness of Speaker:

Question Title

* Additional comments:

Question Title

* Nutrition and Diabetes | Michael Mindrum, MD

Your knowledge of current and evolving nutritional approaches for the prevention and management of diabetes:

  Poor Fair Good Very Good Excellent
Before
After

Question Title

* Effectiveness of Speaker:

Question Title

* Additional comments:

Question Title

* Diabetes and Mental Health | Barry Simon, MD

Your knowledge of approaches for the screening and diagnosis of binge eating disorder and depression in patients with diabetes including specific screening tools:

  Poor Fair Good Very Good Excellent
Before
After

Question Title

* Your knowledge of treatment interventions, both lifestyle and pharmacologic, for depression and binge eating disorder:

  Poor Fair Good Very Good Excellent
Before
After

Question Title

* Effectiveness of Speaker:

Question Title

* Additional comments:

Question Title

* Diabetes and Chronic Kidney Disease | David Cherney, MDCM

Your knowledge of updates in recent evidence for therapies for diabetic kidney disease:

  Poor Fair Good Very Good Excellent
Before
After

Question Title

* Your knowledge of current recommended management strategies for patients with diabetes and chronic kidney disease:

  Poor Fair Good Very Good Excellent
Before
After

Question Title

* Effectiveness of Speaker:

Question Title

* Additional comments:

Additional Feedback 

Question Title

* 2. From what you have learned, how will this impact / modify your practice and what will you be able to apply to your practice? What potential barriers do you anticipate and how will you overcome them?

Question Title

* Please indicate which CanMEDS roles you felt were addressed during this educational activity?

Question Title

* Sessions allocated at least 25% of the time for interaction

Question Title

* Did you perceive any sources of commercial bias in any of the sessions? If so, please explain:    

Question Title

* Did the activity comply with the Code of Ethics for parties involved in continuing medical education?

Question Title

* Were there any topics you think should have been addressed?  Any recommendations for future sessions?

Question Title

* Please share any additional comments:

Thank you!

T